Mira Pharmaceuticals Inc (MIRA) Stock Price

0.9849 ▼ -0.0021 (-0.21%)
Open: 0.9836 Vol: 0 Day's range: 0.9774 - 0.9869 May 11, 11:05 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MIRA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.98▲ 0.98▲ 0.99▼ 1.00▼ 1.02▼
MA10 0.98▲ 0.99▼ 0.99▼ 1.01▼ 1.04▼
MA20 0.99▼ 1.00▼ 1.01▼ 1.04▼ 1.17▼
MA50 1.01▼ 1.02▼ 1.02▼ 1.08▼ 1.33▼
MA100 1.03▼ 1.03▼ 1.04▼ 1.23▼ 1.29▼
MA200 1.04▼ 1.05▼ 1.06▼ 1.34▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ 0.000▼ -0.003▼ -0.003▼ -0.014▼
RSI 37.246▼ 34.578▼ 35.077▼ 40.348▼ 39.801▼
STOCH 31.787     19.824▼ 11.645▼ 10.240▼ 30.133    
WILL %R -61.735     -80.053▼ -80.053▼ -95.387▼ -80.256▼
CCI -2.497     -48.577     -92.276     -129.346▼ -96.986    
Latest Filters Detected On MIRA
CDL $MIRA Hammer Candlestick Pattern Detected Set Alert
CDL $MIRA Doji Star Candlestick Pattern Detected Set Alert
CDL $MIRA Doji Candlestick Pattern Detected Set Alert
Mira Pharmaceuticals Inc News
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data
Thursday, October 16, 2025 07:16 AM
MIRA Pharmaceuticals Inc (NASDAQ:MIRA) shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55. What Happened: MIRA ...
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
Saturday, October 04, 2025 01:32 AM
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA’s advancing programs including Ketamir-2 and MIRA-55 MIAMI, FLORIDA / ACCESS Newswire / September ...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Tuesday, August 19, 2025 05:30 AM
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc.
MIRA historical stock data
date open high low close volume
11/05/26 0.9836 0.9869 0.9774 0.9849 34,422
08/05/26 1.01 1.01 0.981 0.987 76,853
07/05/26 1.02 1.03 0.9901 1.00 106,896
06/05/26 1.02 1.0298 1.00 1.00 102,327
05/05/26 1.0499 1.05 1.01 1.02 112,482
04/05/26 1.02 1.065 1.02 1.03 171,780
01/05/26 1.04 1.06 1.03 1.04 42,897
30/04/26 1.03 1.075 1.015 1.05 202,540
29/04/26 1.01 1.0279 1.00 1.02 72,946
28/04/26 1.03 1.04 1.01 1.01 210,746
Quote Details
52wk Low:0.90
52wk High:2.45
Vol:0
Avg Vol(3m):2.7M
1Y Chng:-26.50%
1M Chng:+2.24%
Add to Watch List
More Information
Index US Composite
Market Cap. 42.02M